High-density lipoprotein cholesterol is associated with lowered cognitive recovery among acute ischemic stroke patients with mild cognitive impairment

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Acta Neurologica Belgica

• Publication date

  2023-09-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13760-023-02375-yPMID 37752321
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume

  2022cited by this paper
• Serum TG/HDL-C level at the acute phase of ischemic stroke is associated with post-stroke cognitive impairment

  2022cited by this paper
• Protein-based HDL subspecies: Rationale and association with cardiovascular disease, diabetes, stroke, and dementia.

  2022cited by this paper
• The Role of High-Density Lipoprotein in Lowering Risk of Dementia in the Elderly: A Review

  2022cited by this paper
• Plasma high-density lipoprotein cholesterol and risk of dementia: observational and genetic studies

  2021cited by this paper
• Association between serum non-high-density lipoprotein cholesterol and cognitive dysfunction after acute ischemic stroke: a cross-sectional study

  2020cited by this paper
• Sex-specific associations between lipids and cognitive decline in the middle-aged and elderly: a cohort study of Chinese adults

  2020cited by this paper
• Levels of non-high-density-lipoprotein cholesterol are positively correlated with the risk of cognitive impairment in patients with intracerebral hemorrhage stroke

  2020cited by this paper
• High-Density Lipoprotein Carries Markers That Track With Recovery From Stroke

  2020cited by this paper
• Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups

  2019cited by this paper
• Oxidative lipoprotein markers predict poor functional outcome in patients with minor stroke or transient ischaemic attack

  2019cited by this paper
• The efficacy and safety of nimodipine in acute ischemic stroke patients with mild cognitive impairment: a double-blind, randomized, placebo-controlled trial.

  2019cited by this paper
• Longitudinal and nonlinear relations of dietary and Serum cholesterol in midlife with cognitive decline: results from EMCOA study

  2019influential reference
• Post-stroke dementia – a comprehensive review

  2017cited by this paper
• Temporal Evolution of Poststroke Cognitive Impairment Using the Montreal Cognitive Assessment

  2017cited by this paper
• Association between serum non-high-density lipoprotein cholesterol and cognitive impairment in patients with acute ischemic stroke

  2016cited by this paper
• HDLs in crises

  2016cited by this paper
• Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study

  2016cited by this paper
• HDL-cholesterol and apolipoproteins in relation to dementia

  2016influential reference
• Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

  2015cited by this paper
• Prevalence of Poststroke Cognitive Impairment: South London Stroke Register 1995–2010

  2013influential reference
• Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)

  2012cited by this paper
• Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease.

  2010cited by this paper
• Role of Cytokines as Mediators and Regulators of Microglial Activity in Inflammatory Demyelination of the CNS

  2010cited by this paper
• Proliferating Resident Microglia after Focal Cerebral Ischaemia in Mice

  2007cited by this paper
• Cognitive recovery after stroke: a 2-year follow-up.

  2003cited by this paper
• Relationships between Cholesterol, Apolipoprotein E Polymorphism and Dementia: A Cross-Sectional Analysis from the PAQUID Study

  2000cited by this paper

• Triglycerides, high-density lipoprotein and cognitive function in middle-aged and older adults: a cross-sectional analysis

  2025cites this paper
• Lipoprotein-a and white matter abnormalities: predicting small vessel disease in young patients with ischemic cerebrovascular events

  2025cites this paper
• Elevated monocyte-to-high-density lipoprotein ratio is associated with increased risk of cognitive impairment and severe cerebral small vessel disease burden

  2025cites this paper
• Risk factors for stroke outcomes in adults: Stroke in China

  2023cites this paper